Mark Massaro
Stock Analyst at BTIG
(4.43)
# 342
Out of 4,874 analysts
136
Total ratings
51.69%
Success rate
19.25%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Buy | $60 | $68.34 | -12.20% | 1 | Apr 21, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $8 → $9 | $12.16 | -25.99% | 5 | Dec 18, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $65 → $75 | $51.81 | +44.76% | 16 | Nov 26, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $3.29 | - | 8 | Sep 10, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.2 → $7 | $9.61 | -27.16% | 6 | Aug 23, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $6.37 | +9.89% | 1 | Aug 16, 2024 | |
| ZTS Zoetis | Maintains: Buy | $220 → $225 | $155.79 | +44.43% | 2 | Aug 12, 2024 | |
| NTRA Natera | Maintains: Buy | $125 → $135 | $168.17 | -19.72% | 13 | Aug 9, 2024 | |
| AKYA Akoya Biosciences | Downgrades: Neutral | n/a | $1.32 | - | 3 | Aug 6, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $35 → $45 | $89.59 | -49.77% | 4 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $50.03 | -0.06% | 2 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $527.78 | +9.89% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $7.16 | +193.30% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $2.30 | +247.83% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.11 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $2.18 | +267.82% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.10 | +158.06% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $19.78 | +51.67% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $6.99 | -28.47% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $19.29 | +29.60% | 2 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.36 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3.5 | $1.19 | +194.12% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $94.16 | +218.61% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $65.11 | -23.21% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $177.06 | -36.74% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $256.98 | -35.79% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $28.70 | +178.75% | 9 | Sep 10, 2018 |
Tempus AI
Apr 21, 2025
Initiates: Buy
Price Target: $60
Current: $68.34
Upside: -12.20%
Adaptive Biotechnologies
Dec 18, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $12.16
Upside: -25.99%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $65 → $75
Current: $51.81
Upside: +44.76%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.29
Upside: -
Ginkgo Bioworks Holdings
Aug 23, 2024
Maintains: Sell
Price Target: $0.2 → $7
Current: $9.61
Upside: -27.16%
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $6.37
Upside: +9.89%
Zoetis
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $155.79
Upside: +44.43%
Natera
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $168.17
Upside: -19.72%
Akoya Biosciences
Aug 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.32
Upside: -
GeneDx Holdings
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $89.59
Upside: -49.77%
Jul 30, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $50.03
Upside: -0.06%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $527.78
Upside: +9.89%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $7.16
Upside: +193.30%
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $2.30
Upside: +247.83%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.11
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $2.18
Upside: +267.82%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $3.10
Upside: +158.06%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $19.78
Upside: +51.67%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $6.99
Upside: -28.47%
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $19.29
Upside: +29.60%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.36
Upside: -
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.19
Upside: +194.12%
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $94.16
Upside: +218.61%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $65.11
Upside: -23.21%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $177.06
Upside: -36.74%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $256.98
Upside: -35.79%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $28.70
Upside: +178.75%